What is the clinical evidence from this study?

Study design: Other. Population: Japanese encephalitis virus (JEV) infection. Intervention: Capture-ELISA based on mAb 20B6 for JEV NS1 protein. Primary outcome: Detection of JEV NS1 protein and cross-reactivity.

What does this research mean for the field?

A newly developed capture ELISA based on the monoclonal antibody 20B6 can specifically and sensitively detect Japanese encephalitis virus (JEV) NS1 protein in biological samples without cross-reactivity to other orthoflaviviruses. Novelty: ClaimNovelty.METHODOLOGICAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To establish a highly sensitive and specific capture-ELISA targeting the Japanese encephalitis virus (JEV) NS1 protein to resolve diagnostic cross-reactivity and short viremic windows.

August 22, 2026AnimalsOpen Access

Development of JEV NS1 Specific Capture-ELISA Based on a Single Monoclonal Antibody

View Full Paper

Ask AI

Bookmark

Key result

Monoclonal antibody 20B6-based ELISA detects JEV NS1 protein without cross-reactivity to other orthoflaviviruses.

Why the study?

Diagnosis of orthoflavivirus infections is hampered by short viremia duration and severe cross-reactivity, highlighting the need for NS1-targeted assays.

Population

Cell culture medium, cell lysates, mouse tissues, and porcine serum samples from JEV-infected subjects

Design

Preclinical laboratory assay development and validation study

Authors

SZShu-Jian ZhangHarbin Veterinary Research Institute JZJianhui ZhangHarbin Veterinary Research Institute SLShi-Meng LiuHarbin Veterinary Research Institute

Discussion

Member takes

Implication

NS1-based testing may extend the diagnostic window for JEV in animals; leaves open validation against cross-reactivity in humans.

Key Points

To establish a highly sensitive and specific capture-ELISA targeting the Japanese encephalitis virus (JEV) NS1 protein to resolve diagnostic cross-reactivity and short viremic windows.
Expressed and purified recombinant JEV NS1 protein in mammalian cells using affinity chromatography to generate seven target-specific monoclonal antibodies (mAbs).
Selected mAb 20B6 based on binding affinity and optimized capture-ELISA coating (3 μg/mL) and detection antibody concentrations (0.432 μg/mL).
Tested cross-reactivity against multiple orthoflaviviruses (WNV, KUNV, USUV, MVEV, SLEV, ZIKV) and swine viruses across cell cultures, mouse tissues, and porcine sera.
Selected monoclonal antibody 20B6 showed the strongest binding affinity to JEV NS1 among all generated candidates.
The optimized capture-ELISA showed complete absence of cross-reactivity with other tested orthoflaviviruses and common porcine viruses.
The assay effectively detected NS1 protein in JEV-infected cell lysates, culture supernatants, mouse tissues, and porcine serum samples.

Structured PICO

Population

Mammalian cells, mouse tissues, and porcine serum samples from JEV-infected subjects

Intervention

Development of a JEV NS1 specific capture-ELISA based on a single monoclonal antibody (mAb 20B6)

Outcome

Specificity and sensitivity of the capture ELISA for JEV NS1 proteinsurrogate

The development of a highly specific and sensitive capture ELISA for JEV NS1 protein provides a potential tool for epidemiological surveillance of Japanese encephalitis.

Cite This Study

Zhang et al. (2026) studied Japanese encephalitis virus (JEV) infection. Capture-ELISA based on mAb 20B6 for JEV NS1 protein was evaluated on Detection of JEV NS1 protein and cross-reactivity. A highly specific and sensitive capture ELISA based on monoclonal antibody 20B6 was developed to detect JEV NS1 protein without cross-reactivity to other orthoflaviviruses.

synapsesocial.com/papers/6a895fe4ca7ade938187ecf3 https://doi.org/10.3390/ani16162601

View Full Paper

Ask AI

Bookmark

Development of JEV NS1 Specific Capture-ELISA Based on a Single Monoclonal Antibody

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Development of JEV NS1 Specific Capture-ELISA Based on a Single Monoclonal Antibody

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Also Consider